Molecular biomarkers in a patient’s DNA can indicate a specific subtype of cancer or other disease, paving the way for more personalized, potentially more effective treatments. But sifting through the ...

NEW YORK--(BUSINESS WIRE)--Paige, a global leader in clinical AI applications in pathology, today announced a collaboration with Janssen Research & Development, LLC (Janssen) to evaluate the potential ...

The term neurogenic bladder is defined as bladder dysfunction resulting from damage to the nerves that control the bladder in ...

Research at Stanford Medicine suggests that a urine test may. be able to determine which patients will benefit from additional therapy.

In this phase IIb parallel cohort study, patients with BCG-unresponsive carcinoma in situ (CIS) with/without papillary disease received TAR-200 monotherapy (Cohort 2 [C2]), TAR-200 plus cetrelimab (C1 ...

Genome-wide molecular characterization of mucinous colorectal adenocarcinoma. Background: In this study, desorption electrospray ionization (DESI) mass spectrometry (MS) was used in an imaging mode to ...

Radical cystectomy, or complete bladder removal, remains the standard and most effective surgery for muscle‑invasive bladder cancer because it offers the strongest chance of cure when the disease has ...

WILMINGTON, Del.--(BUSINESS WIRE)--Results from a post-hoc exploratory subgroup analysis from the NIAGARA Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab), administered perioperatively in ...

Following their research using pigs and brain-dead deceased donors, investigators with Keck Medicine at the University of Southern California in Los Angeles are gearing up to transplant a bladder into ...